| to biomarker identification. |
Magellan designs all its systems, sensors,
and consumables to deliver better, more-
reliable results. And better results help drive
improved health outcomes: earlier, more-
accurate diagnoses; breakthroughs that can
lead to novel treatments, new cures –
innovations to enhance life. A privately held
company, Magellan serves customers through
wholly owned subsidiaries: ESA Biosciences,
Dynex Technologies, and TREK Diagnostic
Systems.
|
